Long-term Data Collection for Subjects in MDX-010 Studies

ClinicalTrials.gov ID: NCT00928031

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00928031. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Collection of Long-Term Outcome Data for Subjects Who Have Previously Participated in Selected Ipilimumab (MDX-010) Studies in Metastatic Melanoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to collect disease status and overall survival information for all Subjects in MDX-010 studies.

Study identification

NCT ID: NCT00928031
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Bristol-Myers Squibb; Industry
Enrollment: 160 participants

Conditions and interventions

Conditions

Metastatic Melanoma

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 2007 (Type not available)
Primary completion: Apr 2009 (Actual)
Completion: Apr 2009 (Actual)
Last update posted: Apr 26, 2010

2007 – 2009

United States locations

U.S. sites: 11
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
Arizona Cancer Center	Tuscon	Arizona	85724	—
Pacific Shores Medical Group	Long Beach	California	90813	—
The Angeles Clinic and Research Institute	Los Angeles	California	90025	—
USC Norris Cancer Center	Los Angeles	California	90033	—
University of Miami Sylvester Cancer Center	Miami	Florida	33136	—
St. Francis Research Foundation	Beech Grove	Indiana	46107	—
Dana-Farber Cancer Institute	Boston	Massachusetts	02115	—
NYU Cancer Institute	New York	New York	10016	—
Carolinas Cancer Care	Charlotte	North Carolina	28211	—
Providence Portland Medical Center	Portland	Oregon	97213	—
Huntsman Cancer Institute	Salt Lake City	Utah	84112	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00928031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 26, 2010 · Synced Nov 15, 2026